Adage reports 821,261 shares (5.34%) of Adagio Medical (ADGM)
Adage Capital Management, L.P., together with individuals Robert Atchinson and Phillip Gross, reported beneficial ownership of 821,261 shares of Adagio Medical Holdings, Inc. common stock, representing 5.34% of the class.
Rhea-AI Filing Summary
Adage Capital Management, L.P., together with individuals Robert Atchinson and Phillip Gross, reported beneficial ownership of 821,261 shares of Adagio Medical Holdings, Inc. common stock, representing 5.34% of the class. The percentage was calculated using 15,381,565 shares outstanding as of May 7, 2025, per the company quarterly report filed May 15, 2025. The Schedule 13G shows shared voting and shared dispositive power over all 821,261 shares and includes a certification that the securities were acquired and are held in the ordinary course of business and not to influence control. The filing lists the issuer office in Laguna Hills, CA, and includes a joint filing agreement as Exhibit 99.1.
Positive
- Reported beneficial ownership exceeds 5%, at 821,261 shares (5.34%), meeting materiality thresholds that require public disclosure
- Filing is on Schedule 13G with a certification that the shares are held in the ordinary course and not to influence control, indicating passive intent
Negative
- None.
Insights
TL;DR: Adage reports a passive 5.34% stake (821,261 shares) in Adagio, disclosed on Schedule 13G.
The filing documents a >5% position held by Adage Capital Management, L.P., with shared voting and dispositive power over 821,261 shares, calculated on 15,381,565 shares outstanding as of May 7, 2025. Because this is a Schedule 13G with a certification that the stake is held in the ordinary course and not to influence control, it is presented as a passive, reportable ownership position rather than an active control attempt.
TL;DR: The Schedule 13G filing signals a reportable, passive substantial holder with shared authority over the position.
The statement names Adage Capital Management, L.P. and two individuals as reporting persons and shows shared voting and dispositive power for all reported shares. The filing includes the required certification and a joint filing agreement (Exhibit 99.1). The use of Schedule 13G and the explicit certification indicate the reporting persons characterize the position as passive under applicable rules.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Adagio Medical (ADGM) did Adage report?
How was the 5.34% ownership calculated for ADGM?
Which reporting persons filed the Schedule 13G for ADGM?
Does the filing indicate Adage seeks to influence control of ADGM?
What voting and dispositive powers are reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.